SIRT1 Alleviates Mitochondrial Fission and Necroptosis in Cerebral Ischemia/Reperfusion Injury via SIRT1–RIP1 Signaling Pathway
MedComm · 2025-03 · 6 (3)
DOI: 10.1002/mco2.70118 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 24.02.2025. Verfasst von Xuan Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases Coll…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Programmed cell death, including necroptosis, plays a critical role in the pathogenesis of cerebral ischemia/reperfusion injury (CIRI). Silent information regulator 1 (SIRT1) has been identified as a potential therapeutic target for CIRI, yet its precise role in regulating necroptosis remains controversial. Furthermore, the potential interaction between SIRT1 and receptor‐interacting protein kinase 1 (RIP1) in this context is not fully understood. Sanpian Decoction (SPD), a classical traditional herbal formula, was previously shown to enhance SIRT1 expression in our studies. Our findings demonstrated that, both in vivo and in vitro, CIRI was associated with a decrease in SIRT1 levels and phosphorylated dynamin‐related protein 1 (p‐DRP1) at Ser637, alongside an increase in RIP1 and other necroptosis‐related proteins. Co‐immunoprecipitation and immunofluorescence analyses revealed a weakened interaction between SIRT1 and RIP1. Furthermore, abnormal mitochondrial fission and dysfunction were mediated through the phosphoglycerate mutase 5–DRP1 pathway. Notably, SPD treatment improved neurological outcomes and reversed these pathological changes by enhancing the SIRT1–RIP1 interaction. In conclusion, this study suggests that SIRT1 is a promising therapeutic target for CIRI, capable of inhibiting necroptosis and mitigating mitochondrial fission via the SIRT1–RIP1 pathway. SPD exhibits therapeutic potential by activating SIRT1, thereby attenuating necroptosis and mitochondrial fission during CIRI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese and Western Medicine Hunan Unive…
- Hunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics Hunan University of Chinese Medicine Changsha Hunan China.
- School of Pharmacy Hunan University of Chinese Medicine Changsha Hunan China.
- Third-Grade Pharmacological Laboratory on Chinese Medicine Approved by State Administration of Traditional Chinese Medicine College of Medicine and Health Sciences China Three Gorges University Yichang Hubei China.
ORCID-Profile: Zhigang Mei
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Wei, X., Guo, H., Huang, G., Luo, H., Gong, L., Meng, P., Liu, J., Zhang, W., & Mei, Z. (2025). SIRT1 Alleviates Mitochondrial Fission and Necroptosis in Cerebral Ischemia/Reperfusion Injury via SIRT1–RIP1 Signaling Pathway. MedComm, 6(3). https://doi.org/10.1002/mco2.70118
Vancouver
Wei X, Guo H, Huang G, Luo H, Gong L, Meng P, et al. SIRT1 Alleviates Mitochondrial Fission and Necroptosis in Cerebral Ischemia/Reperfusion Injury via SIRT1–RIP1 Signaling Pathway. MedComm. 2025;6(3). doi:10.1002/mco2.70118
BibTeX
@article{Wei2025,
author = {Wei, Xuan and Guo, Hanjing and Huang, Guangshan and Luo, Haoyue and Gong, Lipeng and Meng, Pan and Liu, Jiyong and Zhang, Wenli and Mei, Zhigang},
title = {SIRT1 Alleviates Mitochondrial Fission and Necroptosis in Cerebral Ischemia/Reperfusion Injury via SIRT1–RIP1 Signaling Pathway},
journal = {MedComm},
year = {2025},
volume = {6},
number = {3},
doi = {10.1002/mco2.70118}
}
EUVIMED